MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-UP-02-0004574
Swaroop Pharmaceuticals Private Limited - pharma in Aligarh, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹82.25 Cr
▲ 56% YoY
Net profit · FY 2022
₹56.63 Lakh
Net margin 0.7%
EBITDA · FY 2022
₹2.77 Cr
EBITDA margin 3.4%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4 Cr
Issued & subscribed
Open charges
₹12 Cr
Satisfied ₹15.81 Cr
Company age
28 yrs
Est. 1998
Employees · EPFO
18
Provident fund records
About Swaroop Pharmaceuticals Private Limited
Data last updated:
Swaroop Pharmaceuticals Private Limited is a private limited company based in Aligarh, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 May 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24231UP1998PTC023440. Its GSTIN is 09AAICS9143B1ZA (Uttar Pradesh).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4 Cr. It is led by directors including Vineet Kela and Puneet Kela.
Its last annual general meeting (AGM) was held on 28 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Ram Kutir Kela Nagar Aligarh, Uttar Pradesh, India – 202001.
As per the financials filed for FY 2022, the company reported a revenue of ₹82.25 Cr, a growth of 56% compared to the previous year. For the same year it recorded a net profit of ₹56.63 Lakh (net margin 0.7%) and EBITDA of ₹2.77 Cr (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 26% over five years.
The company has about 18 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹12 Cr and satisfied charges of ₹15.81 Cr on record. Court records list 14 cases involving the company, including 8 filed by the company and 6 filed against it; 6 cases are pending.
Swaroop Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-02-0004574). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sppl.in.
Company details
CIN U24231UP1998PTC023440
Registration Number 023440
Incorporation Date 08 May 1998
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-UP-02-0004574
Recognitions & Rankings of Swaroop Pharmaceuticals
Contact details
Swaroop Pharmaceuticals Private Limited's registered office is in Aligarh, Uttar Pradesh. Its website is sppl.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressRam Kutir Kela Nagar Aligarh, Uttar Pradesh, India – 202001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Swaroop Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Swaroop Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Swaroop Pharmaceuticals Private Limited
FY 2024 filings availableSwaroop Pharmaceuticals Private Limited reported revenue of ₹82.25 Cr (up 56% YoY) for FY 2022.
Revenue · FY 2022
₹82.25 Cr ▲ 56%
Net profit · FY 2022
₹56.63 Lakh margin 0.7%
EBITDA · FY 2022
₹2.77 Cr margin 3.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 56%
3 years · compounded
▲ 29%
5 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▼ 64%
3 years · compounded
▼ 20%
5 years · compounded
▼ 9%
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 56% growth in the latest year. EBITDA fell 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹82.25 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.77 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹56.63 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Swaroop Pharmaceuticals Private Limited, buy the company report.
Board of directors of Swaroop Pharmaceuticals Private Limited
Swaroop Pharmaceuticals has 6 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vineet Kela Also directs: Subh Parenteral Private Limited, Vamkg Pharmaceuticals Private Limited, Swaroop Films Private Limited and 1 more | Director | 08 May 1998 | 28 Years 5 Months | Current |
| Puneet Kela Also directs: Swaroop Films Private Limited | Director | 08 May 1998 | 28 Years 5 Months | Current |
| Atul Agrawal | Director | 31 Mar 2008 | 18 Years 6 Months | Current |
| Sanjay Maheshwari | Director | 08 May 1998 | 28 Years 5 Months | Current |
| Vijay Maheshwari | Director | 08 May 1998 | 28 Years 5 Months | Current |
| Jaiprakash Agarwal | Director | 31 Mar 2008 | 18 Years 6 Months | Current |
Auditor
Swaroop Pharmaceuticals Private Limited is audited by DAS MAHESHWARI & COMPANY for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DAS MAHESHWARI & COMPANY | FY 2022 | 007259C |
Shareholding
The shareholding of Swaroop Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Swaroop Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹12 Cr
Satisfied charges
₹15.81 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Dec 2024 | 101029410 | Others | ₹12 Cr | Open | |
| 30 Jul 2020 | 100367699 | Others | ₹65 Lakh | Satisfied | |
| 30 Jul 2020 | 100367710 | Others | ₹1.3 Cr | Satisfied | |
| 16 Mar 2012 | 10344602 | Bank of Baroda | ₹9.9 Cr | Satisfied | |
| 17 Sep 2008 | 10124567 | Bank of India | ₹3.96 Cr | Satisfied |
To see the full charge records of Swaroop Pharmaceuticals Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Swaroop Pharmaceuticals Private Limited has 14 court cases on record: 8 filed by Swaroop Pharmaceuticals, 6 filed against it. 6 cases are pending and 8 are disposed.
Total cases
14
Filed by the company
8
Filed against the company
6
Pending
6
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 8 | 0 | 1 |
| District courts | 6 | 6 | 5 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, UTTARPRADESH | Writ petition | Filed by the company against U.P. Power Corporation Ltd. and 3 Others | Disposed |
| High Court, UTTARPRADESH | Writ petition | Filed by the company against Dakshinanchal Vidyut Vitran Nigam Ltd. and 2 Ors. | Disposed |
| District court, Koraput, Odisha | Court case (2 (c) C.c.) | Filed against the company by Government of Odisha (2(C)Cc. 03 of 2026 | Pending |
| District court, Bargarh, Odisha | Court case (2 (c)cc) | Filed against the company by an individual | Pending |
| District court, Cuttack, Odisha | Court case (2 (c)CC) | Filed against the company by State of Odisha | Pending |
To see the full case history of Swaroop Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Swaroop Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Swaroop Pharmaceuticals Private Limited has a workforce of 18 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
18
Active EPFO establishments
1
Employee growth
-33.33%
GST
Swaroop Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICS9143B1ZA | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Swaroop Pharmaceuticals Private Limited, buy the company report.
Recent activity
Swaroop Pharmaceuticals Private Limited has 6 board changes on record since 1998: 6 appointments. The latest: Atul Agrawal was appointed as Director on 31 Mar 2008.
Charges
A charge registered on 30 Jul 2020 via Charge ID 100367699 with Others was fully satisfied on 15 Jan 2025.
Charges
A charge registered on 30 Jul 2020 via Charge ID 100367710 with Others was fully satisfied on 15 Jan 2025.
Charges
A charge registered on 16 Mar 2012 via Charge ID 10344602 with Bank Of Baroda was fully satisfied on 15 Jan 2025.
Charges
A charge with Others amounted to Rs. 12.00 Cr with Charge ID 101029410 was registered on 18 Dec 2024.
AGM
Swaroop Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records.
Filing
Swaroop Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
Charges
A charge with Others amounted to Rs. 0.65 Cr with Charge ID 100367699 was registered on 30 Jul 2020.
Charges
A charge with Others amounted to Rs. 1.30 Cr with Charge ID 100367710 was registered on 30 Jul 2020.
Charges
A charge with Bank Of Baroda of Rs. 9.90 Cr registered on 16 Mar 2012 with Charge ID 10344602 was modified on 21 Nov 2014.
Charges
A charge registered on 17 Sep 2008 via Charge ID 10124567 with Bank Of India was fully satisfied on 23 Apr 2012.
Charges
A charge with Bank Of Baroda amounted to Rs. 9.90 Cr with Charge ID 10344602 was registered on 16 Mar 2012.
Charges
A charge with Bank Of India of Rs. 3.96 Cr registered on 17 Sep 2008 with Charge ID 10124567 was modified on 08 Jun 2010.
8 earlier events are in the company report.
Frequently asked questions
Swaroop Pharmaceuticals is an active private limited company based in Aligarh, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 May 1998 (28+ years old) and is registered under CIN U24231UP1998PTC023440.
Swaroop Pharmaceuticals has 6 current directors:
- Vineet Kela - Director
- Puneet Kela - Director
- Atul Agrawal - Director
- Sanjay Maheshwari - Director
- Vijay Maheshwari - Director
- Jaiprakash Agarwal - Director
The latest financial statements of Swaroop Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 28 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Swaroop Pharmaceuticals is 09AAICS9143B1ZA, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Swaroop Pharmaceuticals is U24231UP1998PTC023440. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Swaroop Pharmaceuticals has 14 court cases on record: 8 filed by the company and 6 filed against it. 6 are pending. Most are in the high courts.
Swaroop Pharmaceuticals was incorporated on 08 May 1998, making it 28+ years old. It is registered with the Registrar of Companies, Kanpur.
Atul Agrawal was appointed as Director on 31 Mar 2008. Jaiprakash Agarwal was appointed as Director on 31 Mar 2008. Puneet Kela was appointed as Director on 08 May 1998. Swaroop Pharmaceuticals has 6 board changes on record in total.
Yes, Swaroop Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-UP-02-0004574).
Swaroop Pharmaceuticals can be reached through the website sppl.in. Its registered office is in Aligarh, Uttar Pradesh, India.